Ayşegül KARALEZLİ, Hatice Canan HASANOĞLU, Mehmet GÜMÜŞ, Elif TANRIVERDİO, Mehtap AYDIN

A mass of myxofibrosarcoma in the lung

Fibrosarkoma malign fibroblastlar içeren mezenşimal bir tümördür. Miksofibrosarkoma fibrosarkomun değişken miksoid stroma, pleomorfizm ve geniş kıvrımlı damarsal patern gösteren bir varyantıdır. Hastalık 6-8. dekadda sıktır, nadiren 20 yaş altında görülür. Çoğu hasta yavaş büyüyen ağrısız kitle ile başvurur. Olguların çoğunda tümör dermal/subkütan dokudan gelişir. İnfiltratif veya sınırlı seyreder. Tümörün en sık yerleşim yeri ekstremitelerdir (özellikle alt ekstremiteler). Nadiren gövde, kafa içi ve boyun bölgesinde yerleşir. İngilizce literatürde göğüs duvarında miksofibrosarkomalı olguya rastlanmamıştır. Biz bu bildiride göğüs duvarında miksofibrosarkoma gelişen bir olgu sunduk.

Göğüs duvarında miksofibrosarkomalı bir olgu

Fibrosarcoma is a mesenchymal tumor constituted by malignant fibroblasts. Myxofibrosarcoma is one of the fibrosarcoma variants that mostly develops from dermal/subcutaneous tissues. The most common locations are the limbs, with rare occurrences in the chest, head, and neck. Since, to best of our knowledge, there is no such report in English literature, we hereby present a case of lung myxofibrosarcoma. A 47-year-old man who had chest pain for 4 months was admitted to our clinic. The chest X-ray revealed a homogeneous density in the left upper lung. His chest computed tomography (CT) scan showed a solid mass lesion of 52 x 58 mm in size at the apical segment of the left upper lobe. There was tumor invasion at the second and third ribs. CT-guided fine-needle tru-cut lung biopsy was performed. Histopathological evaluation result was high grade myxofibrosarcoma. Surgery was conducted. Myxofibrosarcoma is a surgically curable disease. However, local recurrences occur in 50% to 60% of the cases. Therefore, chemotherapy and/or radiotherapy is the suggested approach following surgery.

PDF

___

1. Mentzel T, Van den Berg E, Molenaar WM. Myxofibrosarcoma. In: Fletcher CDM, Unni KK, Mertens F (eds). WHO classification of tumours-Pathology and genetics, tumors of soft tissue and bone. Lyon: IARC Press, 2002; 102-3.
2. Huang H, Lal P, Qin J, et al. Low-Grade Myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Human Pathology May 2004; 35: 612-21.
3. Angervall L, Kindblom LG, Merck C. Myxofibrosarcoma. A study of 30 cases. Acta Pathol Microbiol Scand A 1977; 85: 127-40.
4. Mentzel T, Calonje E, Wadden C, et al. Myxofibrosarcoma: clinicopathologic analysis of 75 cases with emphasis on the low grade variant. Am J Surg Pathol 1996; 20: 391-405.
5. Graadt van Roggen J, Hogendoorn P, Fletcher C. Myxoid tumours of soft tissue. Histopathology 1999; 35: 291-312.
6. Fujımura T, Okuyama R, Terui T, et al. Myxofibrosarcoma (myxoid malignant fibrous histiocytoma) showing cutaneous presentation: report of two cases. J Cutan Pathol 2005; 32: 512-5.
7. Merck C, Angervall L, Kindblom LG, Oden A. Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathologic and prognostik study of 110 cases using multivariate analysis. Acta Pathol Microbiol Immunol Scand Suppl 1983; 282: 1-40.
8. Lin CN, Chou SC, Li CF, et al. Prognostic factors of myxofibrosarcomas: implications of margin status, tumor necrosis, and mitotic rate on survival. J Surg Oncol 2006; 93: 294-303.